KORU Medical raises 2026 revenue guidance to $48 million-$48.5 million
KRMD•KORU Medical raised its fiscal 2026 revenue guidance to $48 million-$48.5 million, or 17%-18% year-over-year growth, and forecast gross margin of 63%-64%, positive adjusted EBITDA and year-end cash above $8 million.
1. Raised outlook
KORU Medical raised its fiscal 2026 revenue guidance to $48 million-$48.5 million, representing 17%-18% year-over-year growth. It forecast gross margin of 63%-64%, positive adjusted EBITDA and year-end cash exceeding $8 million.
2. Revenue and targets
Year-to-date revenue rose 17% to $35.4 million. Long-term targets include $100 million in revenue and an EBITDA margin above 20%.




